Signum Biosciences Chia Seed Extract Patent Granted
Summary
The USPTO granted patent US12599642B2 to Signum Biosciences Inc on April 14, 2026. The patent covers compositions derived from Salvia hispanica (chia) seeds and methods of preparation and administration. The 18 claims span dermatological applications including skin care and sunscreen formulations. Third parties face no compliance obligations from this patent grant.
What changed
The USPTO granted patent US12599642B2 for compositions derived from Salvia hispanica (chia) seeds and methods of preparing and administering chia seed extracts. The patent names 8 inventors and includes 18 claims covering dermatological applications including skin care and sun protection products.
For manufacturers and researchers in the pharmaceutical and food sectors, this patent establishes IP rights that may restrict development of competing chia seed extract products for similar applications until the patent's expiration. Parties should conduct freedom-to-operate analyses before commercializing related products.
Archived snapshot
Apr 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Compositions derived from Salvia hispanica seeds
Grant US12599642B2 Kind: B2 Apr 14, 2026
Assignee
SIGNUM BIOSCIENCES INC
Inventors
Jose Fernandez, Eddie Perez, Kristen Huber, Jason Healy, Corey Webb, Karl Rouzard, Mike Voronkov, George Nikonov
Abstract
Methods of preparing a composition from chia seeds are provided. Compositions, including compositions prepared by the presently disclosed methods, and methods regarding selecting chia seeds and administering chia seed extracts are also disclosed.
CPC Classifications
A61K 36/537 A61K 2236/15 A61K 2236/33 A61K 2236/37 A61K 2236/51 A61K 2236/53 A61K 8/9789 A61K 2236/00 A61K 9/0014 A61Q 19/00 A61Q 17/04 A61P 17/00 A61P 17/06 A61P 25/00 A61P 25/28 A61P 31/04
Filing Date
2021-03-04
Application No.
17909387
Claims
18
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.